Similarly, Cheng and colleagues isolated CTCs from 32 GC patients and demonstrated that a total CTC pool and CTC-PD-L1 were highly correlated with the clinical outcome of checkpoint blockade therapy. This evidence concerns the gene CD274 and gastric cancer.